August 24, 2021
Contact
Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559
Contact Media Relations
(410) 706-5260
Related stories
Tuesday, December 07, 2021
UM School of Medicine's Department of Radiation Oncology Announces that Preeminent Scientist, Dr. Zeljko Vujaskovic, will Transition to New Role in the Department
University of Maryland School of Medicine (UMSOM) Radiation Oncology Department Chair William F. Regine, MD, FACR, FACRO, announced today that Zeljko Vujaskovic, MD, PhD, Professor and Vice Chair for Research in the Department of Radiation Oncology, will transition from his current faculty position to a new role in the Department, effective December 3, 2021.
Monday, October 08, 2018
High-Precision Proton Therapy More Effective in Treating Certain Cancers When Combined with Thermal Therapy
The Maryland Proton Treatment Center (MPTC) is now offering deep-tissue external thermal therapy in combination with high-precision proton-beam radiotherapy as a potential way to boost survival chances for certain cancer patients. MPTC is the only center in the world to offer these two treatments at the same facility, an advantage to patients because these therapies are typically given within an hour of each other.
Monday, September 24, 2018
University of Maryland School of Medicine Researchers to Present Original Research at Key Radiation Conference
The University of Maryland School of Medicine (UMSOM) announced that the Division of Translational Radiation Science (DTRS) will participate in the annual meeting of the Radiation Research Society (RRS) on September 23-26, 2018, in Chicago.
Wednesday, October 18, 2017
University of Maryland School of Medicine Scientists Set to Begin Critical Radiation Countermeasures Research
University of Maryland School of Medicine (UM SOM) Department of Radiation Oncology Chair and Professor William F. Regine, MD, FACR, FACRO, and UM SOM Dean E. Albert Reece, MD, PhD, MBA, announced today that UM SOM researchers have been awarded a contract worth up to $9.7 million over three years, from the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services to study new ways to treat radiation-induced bleeding disorders. BARDA is part of the Office of the Secretary for Preparedness and Response in the U.S. Department of Health and Human Services.
Tuesday, December 06, 2016
Researchers Combine MERS and Rabies Viruses to Create Innovative 2-For-1 Vaccine
In a new study, University of Maryland School of Medicine (UM SOM) researchers have modified a rabies virus, so that it has a protein from the MERS virus; this altered virus works as a 2-for-1 vaccine that protects mice against both Middle East Respiratory Syndrome (MERS) and rabies.
Wednesday, April 13, 2016
Leading Physician-Scientist at University of Maryland School of Medicine Receives Award for Innovative Work in Thermal Treatment for Cancer
Zeljko Vujaskovic, MD, PhD, an internationally recognized physician scientist and Professor of Radiation Oncology at the University of Maryland School of Medicine (UM SOM), will receive the 2016 J. Eugene Robinson Award at the annual Society for Thermal Medicine Meeting in New Orleans, held April 11 to 15. Dr. Vujaskovic, who is also Director of the Division of Translational Radiation Sciences in the UM SOM Department of Radiation Oncology, and Director of the Maryland Proton Alliance at UM SOM, will receive the award in recognition of his contributions to hyperthermic oncology, the use of heat to treat cancer. At the event, Dr. Vujaskovic will also present a lecture on the reemerging role of thermal therapy in cancer treatment.
Friday, January 15, 2016
UM SOM to Participate in Expanded Medical Countermeasures Research Project
University of Maryland School of Medicine (UM SOM) Department of Radiation Oncology Chair and Professor William F. Regine, MD, FACR, FACRO, and UM SOM Dean E. Albert Reece, MD, PhD, MBA, announced today that researchers at the UM SOM have been selected as key contractors by the Biomedical Advanced Research and Development Authority (BARDA), for its Radiation Nuclear Animal Model Development program. BARDA is part of the Office of the Secretary for Preparedness and Response in the U.S. Department of Health and Human Services (DHHS).